Cosmetic cross-reference

Magnesium Citrate

CAS 3344-18-1

Magnesium Citrate (CAS 3344-18-1) is a Phase 3 pharmaceutical compound with 0 bioactivity targets and 2,544 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
2,544
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Magnesium Citrate
CAS Number
3344-18-1
UNII
RHO26O1T9V
InChIKey
PLSARIKBYIPYPF-UHFFFAOYSA-H
ChEMBL ID
CHEMBL3989480
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3
Late-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL3989480 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 26 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Visual snow syndrome 8 48.025 10079450
Gastrooesophageal reflux disease 55 39.891 10017885
Constipation 96 39.693 10010774
Tetany 13 37.789 10043380
Drug use disorder 18 37.172 10079381
Focal segmental glomerulosclerosis 13 34.922 10067757
Rhonchi 13 32.035 10039109
Blepharospasm 15 31.877 10005159
Anticipatory anxiety 9 29.104 10002758
Asthenia 122 28.696 10003549
Taste disorder 18 24.297 10082490
Night sweats 29 22.2 10029410
Hypermagnesaemia 7 20.812 10020669
Muscle spasms 56 20.517 10028334
Nerve block 6 19.315 10029173
Pruritus allergic 7 18.815 10063438
Hyperaesthesia 13 18.515 10020568
Facet joint syndrome 13 18.354 10054813
Burkholderia test positive 6 17.751 10069960
Fatigue 181 15.74 10016256
Gastric varices 5 15.393 10051012
Lip dry 13 15.153 10024552
Abdominal pain upper 58 15.052 10000087
Adverse drug reaction 32 14.887 10061623
Peripheral venous disease 13 14.593 10075049
Blood magnesium decreased 13 14.473 10005654

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
MAGNESIUM CITRATE 52356 SU MTHSPL
magnesium citrate 52356 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Magnesium Citrate used for in pharmaceutical contexts?

Magnesium Citrate (CAS 3344-18-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Magnesium Citrate?

Magnesium Citrate has 2,544 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Visual snow syndrome, Gastrooesophageal reflux disease, Constipation, Tetany, Drug use disorder. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Magnesium Citrate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Magnesium Citrate with EU status "permitted".

What clinical phase is Magnesium Citrate in?

Magnesium Citrate is rendered with ChEMBL max phase 3.